logo

Pavmed Inc (PAVM)



Trade PAVM now with
  Date
  Headline
11/28/2017 8:18:01 AM PAVmed Says Files 510(k) Submission With FDA For CarpX Device To Treat Carpal Tunnel Syndrome
11/15/2017 7:36:09 AM PAVmed Q3 Net Loss Attributable To Common Stockholders $5.37 Mln Or $0.40/8Shr Vs Loss $1.93 Mln Or $0.14/shr Last Year
8/14/2017 7:40:41 AM PAVmed Q2 GAAP Loss Attributable To Common Stockholders $1.04 Mln Or $0.08/Shr Vs Loss $1.31 Mln Or $0.10/Shr Last Year
7/5/2017 7:33:44 AM PAVmed Inc. Closes $5 Mln Financing Provided By Scopia Holdings
5/22/2017 4:10:06 PM PAVmed Q1 Loss/share $0.32 Vs. Loss $0.06 Year Ago
3/28/2017 7:17:05 AM PAVmed Announces Filing Of Registration Statement On Form S-1 Relating To Private Placement
3/21/2017 7:33:40 AM PAVmed Appoints Dennis McGrath As Its New EVP And CFO